Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-004616
Filing Date
2022-02-03
Accepted
2022-02-03 16:41:58
Documents
1
Period of Report
2022-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3971
  Complete submission text file 0000899243-22-004616.txt   5308
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVALENT, INC. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Conley Emily (Reporting) CIK: 0001907812 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 22589241